spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  pulmonary fibrosis 

 HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 20 Jul 2022
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Devices Venture Capital
 HSMN NewsFeed - 16 Sep 2021
LUMAKRAS(TM) (Sotorasib) Combined With Vectibix(R) (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Apr 2021
United Therapeutics Announces FDA Approval and Launch of Tyvaso(R) for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 23 Feb 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2021
Protalix BioTherapeutics Enters into an Exclusive Partnership with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Respiratory Diseases Via Inhaled Delivery
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 3 Mar 2020
Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Oct 2019
Third Pole Therapeutics Names Bill Athenson New CEO
Devices Drug Delivery Personnel
 HSMN NewsFeed - 23 Oct 2019
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2019
Encoded Therapeutics Expands Leadership Team with Key Appointments, Adding Expertise in Manufacturing and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory
 HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Aug 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jul 2018
Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2017
Veracyte Announces Executive Promotions
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 Feb 2017
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
Biopharmaceuticals Mergers & Acquisitions Venture Capital
 HSMN NewsFeed - 10 Nov 2016
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals
 HSMN NewsFeed - 12 Oct 2016
Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2016
VolitionRx Announces CE Marks for Two NuQ(R) Blood Assays for Detection of Colorectal Cancer
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 30 Mar 2016
Curis Announces Expansion of Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2016
Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma(R) Gene Expression Classifier in Thyroid Cancer Diagnosis
Diagnostics Oncology
 HSMN NewsFeed - 12 Feb 2016
Apellis Completes $47 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2016
Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma(R) Gene Expression Classifier
Diagnostics Oncology
 HSMN NewsFeed - 8 Dec 2015
Pulmatrix Appoints Mark Iwicki Chairman of the Board
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Nov 2015
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Sep 2015
Bellerophon Therapeutics Announces Leadership Team Changes
Devices Drug Delivery Personnel
 HSMN NewsFeed - 17 Aug 2015
Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 25 Jun 2015
Pulmatrix Appoints William Duke, Jr., as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2015
European Commission Approves Amgen's Vectibix(R) (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Aug 2014
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Mar 2014
Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2013
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2013
PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Jan 2013
La Jolla Pharmaceutical Company Adds to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2012
Genoa Pharmaceuticals announces $1.2M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Oct 2012
Promedior Appoints Elizabeth Trehu, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology
 HSMN NewsFeed - 6 Aug 2012
Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatment With Pluristem's PLX Cells
Regenerative Medicine Oncology
 HSMN NewsFeed - 27 Jun 2012
Kedem Pharmaceuticals to Appoint New Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2011
Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2011
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Dec 2010
Gilead Sciences to Acquire Arresto Biosciences for $225 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Mar 2010
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2008
Abbott's HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 18 Sep 2008
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 May 2008
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Apr 2008
InterMune Announces Progress on Pirfenidone in IPF
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2008
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
Biopharmaceuticals Litigation
 HSMN NewsFeed - 11 Mar 2008
Pipex Pharmaceuticals Announces Cost Reduction Measures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Feb 2008
Promedior Adds to Management Team and Announces Extension of Series A Financing
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Nov 2007
InterMune Buys Out License Agreement for Pirfenidone
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2007
Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Sep 2007
NEOPHARM Announces Management Appointment
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Sep 2007
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2007
The Eloxatin(R)-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
FOLFOX4 (Eloxatin(R)-based Chemotherapy) After Surgery Improves Overall Survival in Patients With Early (Stage III) Colon Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Apr 2007
Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2007
Bosentan -- Tracleer -- Receives Positive EU Opinion for Reduction of New Digital Ulcerations in Systemic Sclerosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2007
Respironics' I-neb(R) Device Utilized in Clinical Evaluation Of Interferon Gamma in Idiopathic Pulmonary Fibrosis Patients
Devices
 HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Pipex Therapeutics Merges With Sheffield Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2006
InterMune Closes Collaboration Agreement With Roche
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 May 2006
Actelion: ATS Presentation Highlights Strong Rationale for a Morbidity/Mortality Study with Bosentan in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2006
BioE Stem Cell First Human Cord Blood Stem Cell to Turn into Lung Cell
Regenerative Medicine
Return to NewsFeed  

 Additional items found! 52

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 52 additional stories matching:
pulmonary fibrosis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.